# Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile

> **NCT01744730** · PHASE1 · COMPLETED · sponsor: **Phillip Brian Smith** · enrollment: 22 (actual)

## Conditions studied

- Bacterial Infections
- Obesity

## Interventions

- **DRUG:** Clindamycin

## Key facts

- **NCT ID:** NCT01744730
- **Lead sponsor:** Phillip Brian Smith
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2016-11-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01744730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01744730, "Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01744730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*